Nidan Laborator.
NSE: NIDAN · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Nidan Laborator.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Nidan Laboratories & Healthcare Ltd provides comprehensive diagnostic and healthcare services. The company operates a network of 35 diagnostic centres across Greater Mumbai under the Nidan Diagnostics brand.
Business Model
The company generates revenue by providing diagnostic imaging and testing services, including CT scans, MRIs, ultrasounds, 2D echos, and ECGs. It operates through a physical network of diagnostic centres located within the Greater Mumbai region.
- Diagnostic Centres:35
Growth Outlook
Growth is expected to be driven by the expansion of diagnostic service offerings and the maintenance of its established footprint in the Mumbai healthcare market.
Key Risks
- Regulatory Compliance. The diagnostic sector is subject to stringent healthcare regulations and licensing requirements that may impact operational costs.
- Competitive Intensity. The healthcare diagnostic market in Mumbai is highly fragmented and competitive, which may exert pressure on pricing and margins.
- Technological Obsolescence. Rapid advancements in diagnostic technology require continuous capital expenditure to maintain service quality and market relevance.
Start your research today
Unlock AI insights, financials, peers and live data on Nidan Laborator. and 5,000+ companies — free.
Peers · Healthcare Service Provider
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Nidan Laborator.NIDAN | ₹19 Cr | — | — | — | 18.9% | — | — | -29.9% |
Suraksha Diagnostic Ltd.SURAKSHA | ₹1,851 Cr | 50.02 | 17.47 | 22.5% | 32.7% | 15.8% | 18.6% | +17.7% |
Krsnaa Diagnostics Ltd.KRSNAA | ₹1,817 Cr | 18.46 | 8.75 | 10.2% | 32.5% | 10.5% | 13.3% | -28.2% |
3B BlackBio Dx Ltd3BBLACKBIO | ₹1,229 Cr | 25.08 | 14.76 | 54.3% | 52.8% | 19.0% | 24.1% | +18.1% |
One Global Service Provider LimitedONEGLOBAL | ₹1,062 Cr | 13.88 | 10.52 | 161.6% | 19.4% | 69.4% | 92.5% | +93.2% |
Gaudium IVF and Women Health LimitedGAUDIUMIVF | ₹857 Cr | — | — | — | 36.0% | — | — | — |
As of Mar 2026
Financials
Nidan Laborator.
NSE: NIDAN · Healthcare Service Provider
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Nidan Laborator.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Nidan Laboratories & Healthcare Ltd provides comprehensive diagnostic and healthcare services. The company operates a network of 35 diagnostic centres across Greater Mumbai under the Nidan Diagnostics brand.
Business Model
The company generates revenue by providing diagnostic imaging and testing services, including CT scans, MRIs, ultrasounds, 2D echos, and ECGs. It operates through a physical network of diagnostic centres located within the Greater Mumbai region.
- Diagnostic Centres:35
Growth Outlook
Growth is expected to be driven by the expansion of diagnostic service offerings and the maintenance of its established footprint in the Mumbai healthcare market.
Key Risks
- Regulatory Compliance. The diagnostic sector is subject to stringent healthcare regulations and licensing requirements that may impact operational costs.
- Competitive Intensity. The healthcare diagnostic market in Mumbai is highly fragmented and competitive, which may exert pressure on pricing and margins.
- Technological Obsolescence. Rapid advancements in diagnostic technology require continuous capital expenditure to maintain service quality and market relevance.
Start your research today
Unlock AI insights, financials, peers and live data on Nidan Laborator. and 5,000+ companies — free.
Peers · Healthcare Service Provider
As of Mar 2026